Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Exposure to common cancer treatments within 3 months ...

Blood clots represent a significant burden to the healthcare system. Venous thromboembolism (VTE) includes blood clots that form in the deep veins of the legs, as well as those in the lungs. A clot ...

Continuing oral anticoagulants (OACs) in unprovoked venous thromboembolism (VTE) beyond the 90-day mark provides substantial protection against VTE recurrence and lowers mortality, benefits that ...